Sean Brynjelsen is President and Chief Executive Officer of Eton Pharmaceuticals, Inc. (ETON). The company reported total compensation of $2,914,489 for fiscal year 2025.
| Salary | $712,433 |
|---|---|
| Bonus | $0 |
| Stock awards | $936,052 |
| Option awards | $893,712 |
| Non-equity incentive plan | $354,792 |
| Pension and non-qualified deferred compensation | $0 |
| All other compensation | $17,500 |
| Total | $2,914,489 |
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed, without adjustment.
Cited to the compensation disclosure Eton Pharmaceuticals, Inc. filed April 24, 2026, accession 0001437749-26-013313.
| Fiscal year | Role | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension / NQDC | All other | Total |
|---|---|---|---|---|---|---|---|---|---|
| FY2025 | President and Chief Executive Officer | $712,433 | $0 | $936,052 | $893,712 | $354,792 | $0 | $17,500 | $2,914,489 |
| FY2024 | President and Chief Executive Officer | $615,536 | $0 | $0 | $1,295,283 | $487,304 | $0 | $13,800 | $2,411,923 |
Totals as disclosed in each year's own compensation disclosure for Eton Pharmaceuticals, Inc..
| Named executive officer | Role | FY2025 total |
|---|---|---|
| Sean Brynjelsen this page | President and Chief Executive Officer | $2,914,489 |
| James Gruber | Chief Financial Officer | $1,398,068 |
| David Krempa | Chief Business Officer | $1,394,745 |
| Ipek Erdogan-Trinkaus | Chief Commercial Officer | $575,292 |
The company's named executive officers for fiscal year 2025, and what it reported for each. See the full Eton Pharmaceuticals, Inc. compensation brief.
Sean Brynjelsen's compensation sits inside Eton Pharmaceuticals, Inc.'s full executive and board picture — the peer group, pay against peers, incentive design and the board itself.